X0206 3 2023-04-24 0 0001228627 Ocuphire Pharma, Inc. OCUP 0001974660 Patel Ronil A. C/O OCUPHIRE PHARMA, INC. 37000 GRAND RIVER AVE, SUITE 120 FARMINGTON HILLS MI 48335 true SVP, Operations & Bus. Dev. Common Stock 22304 D Employee Stock Option (right to buy) 6.04 2031-03-24 Common Stock 18000 D Employee Stock Option (right to buy) 5.37 2031-06-30 Common Stock 20000 D Employee Stock Option (right to buy) 2.9 2032-01-27 Common Stock 18800 D Employee Stock Option (right to buy) 2.24 2032-08-31 Common Stock 15000 D Employee Stock Option (right to buy) 3.5 2033-01-09 Common Stock 25956 D The option vests in twenty-four (24) equal monthly increments of 750 shares on the last day of each month from April 2021 through March 2023. 5,000 shares vested on June 30, 2022, then 416 shares vest at the end of each month from July 2022 through May 2025, and 440 shares vest at the end of June 2025. The option vested with respect to 4,700 shares on January 28, 2023, and then with respect to 391 shares on the last day of each month from February 2023 through December 2025 and with respect to 415 shares at the end of January 2026. The option vests with respect to 3,750 shares on September 1, 2023, and then with respect to 312 shares on the last day of each month from September 2023 through July 2026 and with respect to 330 shares at the end of August 2026. 25% of the shares subject to the option vest on the first anniversary of the grant date, with the balance vesting quarterly in 12 equal installments thereafter. Exhibit 24, Power of Attorney, is attached. /s/ Emily J. Johns, by Power of Attorney 2023-04-26